We are proud to invest in tools that elevate our standard of care and help more people live longer, healthier lives.”— ...

These drives reflect our commitment to community health, not just in February, but year-round—especially as we look ...

SHANGHAI, 21st February, 2026 (WAM) -- A Chinese research team has developed an AI-powered rare disease diagnostic system called DeepRare, setting a new record for diagnostic accuracy, according to a ...

The multi‑year renewal strengthens ABL’s integrated platform, improving revenue visibility and supporting the Group’s ...

The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.

ACTON, Mass., Feb. 20, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: BJDX) today announced that as of February 19, 2026, all of the prefunded warrants issued by the Company in its October 2025 private placement ...

Nexstim Receives Clearance for its NBS 6 Diagnostics System in UAE Nexstim Plc ("Nexstim" or "Company") has received import clearance for its ...

LEX, which is based at Melbourn Science Park, was founded in 2020 as a spin-out from TTP Group. The FDA application for VELO ...

Ultra-fast point-of-care molecular diagnostics platform for key respiratory pathogens delivers results in under ten minutes ...

Nexstim’s Therapy Business markets and sells the NBS System 6 which is FDA-cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States.

Milford, Ohio / Syndication Cloud / February 19, 2026 / TurfGrass Experts Spring and summer often bring anxiety to ...

Nigeria’s public health system has taken a further step toward strengthening diagnostic self-reliance with the local ...